Independent profile. Not owned, sponsored or endorsed by CVS Health.

CVS Health Reviews, Complaints & Contacts

CVS Health Corporation of Woonsocket, Rhode Island, is the parent of CVS Pharmacy, the CVS Caremark pharmacy benefit manager, MinuteClinic and Aetna. This page shows where to take a store, pharmacy or Caremark complaint and how to escalate it, gives the BBB and Trustpilot figures for CVS Pharmacy, and summarizes the $315 million Justice Department settlement, the proposed FTC settlement with Caremark, the main court cases and the website privacy settlement.

REVIEWS & COMPLAINTS645on USAComplaints · none in last 3 yrs · latest 2015
PHONE800-746-7287Customer service
WEBSITEcvshealth.com
HEADQUARTERSWoonsocket, RI
PROFILE CHECKED2026-11-05
Submit a Complaint Read reviews & complaints ↓ Call 800-746-7287 Official website ↗

Contacts

PhoneAddress

Customer service & general contact

Corporate & press

Other contacts

VERIFIED

Locations

  • Headquarters1 CVS Drive Woonsocket RI 02895
EDITORIAL

Company Information

BBB, Trustpilot

Legal name
CVS Health Corporation
Founded
1963
Business type
Health company and public parent of CVS Pharmacy retail pharmacies, the CVS Caremark pharmacy benefit manager, MinuteClinic and Aetna, headquartered in Woonsocket, Rhode Island
Website
cvshealth.comSource: cvshealth.com Contact page, checked 2026-11-01
Headquarters
Woonsocket, RISource: cvshealth.com Contact page, corporate headquarters, checked 2026-11-01

CVS Health Corporation is a publicly traded company that files reports with the SEC and is headquartered at 1 CVS Drive, Woonsocket, Rhode Island. BBB lists 1963 as the business start date of CVS Pharmacy, Inc., rates it A+ and shows that it is not BBB accredited. Customer reviews are far less favorable: 1.09 out of 5 on BBB and 1.5 out of 5 on Trustpilot.

The company is also a party to several government matters: the $315 million Justice Department settlement of October 2026 over controlled-substance dispensing, with no determination of liability; a proposed FTC settlement with Caremark over insulin and rebate practices; a 2025 insulin-pen settlement in which CVS admitted certain conduct; and two False Claims Act judgments, one against Omnicare and CVS Health Corporation that CVS has agreed to resolve, and one against Caremark that CVS has appealed. These matters concern company-wide practices and say nothing about a particular store or order. A problem with one pharmacy is best raised with that store's pharmacist-in-charge or manager, then CVS customer service, then your state board of pharmacy.

EXTERNAL SOURCE

Independent Sources

Shown for context — not merged with USAComplaints' own numbers.

BBBComplaints in the last 3 years, CVS Pharmacy, Inc. headquarters profile
404 reviews · 2,064 complaints · BBB business grade A+ · average customer rating 1.09 / 5
TrustpilotAll reviews, CVS Pharmacy profile for www.cvs.com
3,141 reviews · TrustScore 1.5 / 5
EDITORIAL

Complaint Themes

mail-order and Caremark prescription delivery, coverage or customer-service accountsprescription errors, wrong or missing medication, refill delays at store pharmaciespricing, coupon, ExtraCare card or checkout disputesstaff conduct and store service accounts

Themes summarize what people write about most often. One complaint can touch several themes, and some complaints (a positive report, or one later retracted by its author) fit none, so themes are not a count of complaints.

CONSUMER ALLEGATION

Reviews & Complaints on USAComplaints

USAComplaints currently maintains 645 historical complaints about CVS Health, published between 2000 and 2015. No approved complaints have been published on this site during the last three years. For a current reputation snapshot, see the independent sources on this page.

Show 15 more on this page
EDITORIAL

Complaint record: BBB, Trustpilot and this site's archive

BBB. BBB's profile for CVS Pharmacy, Inc. at the Woonsocket, Rhode Island headquarters shows 2,064 complaints in the last 3 years and customer reviews averaging 1.09 out of 5 stars from 404 reviews. CVS Pharmacy is not BBB accredited; BBB gives it an A+ rating.

Trustpilot. The Trustpilot profile for CVS Pharmacy (www.cvs.com) shows a TrustScore of 1.5 out of 5 from 3,141 reviews. The profile is unclaimed, meaning CVS does not answer reviews there, and Trustpilot does not fact-check what reviewers write.

Each platform counts in its own way, so the figures are shown side by side and never added together.

Complaints published on this site. 645 published complaint reports are linked to this profile. They date from 2000 to 2015 and are individual consumer accounts about many different stores and services. Most concern mail-order and Caremark deliveries and coverage, prescription errors and refill delays at store pharmacies, prices, coupons and ExtraCare rewards at checkout, and the conduct of store staff and managers.

Had an experience with CVS Health? Tell other people what happened.

Submit a Complaint
EDITORIAL

CVS complaints: where to take a pharmacy, Caremark or privacy problem

Start with the people closest to the problem, and keep the prescription label or order number, receipts, the store number and the dates and names of everyone you spoke to. Each step on this page works better with that record in hand.

  • At the store pharmacy. Ask for the pharmacist-in-charge or the store manager. A wrong medication, wrong dose or missing refill should be raised with the pharmacist immediately, and with your prescriber if you have already taken the medication.
  • CVS customer service. cvs.com lists 1-800-SHOP-CVS (1-800-746-7287) for questions and feedback about its stores, pharmacies and policies, Monday to Friday 8:30 a.m. to 7 p.m. and Saturday and Sunday 10 a.m. to 6:30 p.m. Eastern, plus an email form answered within two business days; cvshealth.com gives the same number for the corporate headquarters at 1 CVS Drive, Woonsocket, Rhode Island 02895 and refers detailed support to each brand's own site (CVS Pharmacy, MinuteClinic, CVS.com and app, CVS Caremark).
  • CVS Caremark (prescriptions through a health plan or employer). Call the Customer Care number printed on your member ID card; the Caremark contact page also offers a secure message center and, for some members, chat. If a drug is denied or not covered, ask for a coverage decision in writing and then use the appeal process your plan describes. For a Medicare Part D plan, ask the plan for a redetermination within 65 days of the date on the denial notice; if the plan upholds the denial, the next step is an independent review entity, and you can also complain to Medicare at 1-800-MEDICARE (1-800-633-4227).
    More detailShow less

    For an employer plan, the summary plan description sets the appeal route; the U.S. Department of Labor's Employee Benefits Security Administration answers questions about employer health plans at askebsa.dol.gov or 1-866-444-3272, and if your coverage is an insurance policy rather than a self-funded employer plan, your state insurance department also takes complaints.

  • State board of pharmacy. Each state's board of pharmacy licenses pharmacies and pharmacists and investigates complaints about dispensing errors, delays and unsafe conditions. In 2024 the Ohio board, for example, fined a CVS store in Canton $250,000 over understaffing and put it on probation, and separately settled cases involving 22 other Ohio CVS stores.
  • Medical privacy. If you believe a pharmacy disclosed your health information improperly, you can file a HIPAA complaint with the U.S. Department of Health and Human Services Office for Civil Rights, generally within 180 days of when you learned of it.
  • Charges on a card. For a disputed charge on a cvs.com order or a store purchase made by credit card, you can dispute it with your card issuer in writing within 60 days of the statement that first showed it, under the Fair Credit Billing Act.
  • State attorney general, FTC and BBB. Your state attorney general's consumer-protection office takes complaints about retail and pharmacy-benefit practices; the FTC accepts reports at ReportFraud.ftc.gov; and BBB forwards complaints to CVS through its profile for CVS Pharmacy, Inc.
  • Website and app privacy settlement. If you used a CVS website or app in the United States before July 27, 2026, you can file a claim by November 16, 2026 at cvsdigitalprivacysettlement.com for up to $5, or up to $10 with proof of class membership. To keep the right to sue on your own you must opt out by November 2, 2026. Payment depends on the court granting final approval; the terms are in the court-cases section.
EDITORIAL

Government and regulator matters

U.S. Justice Department, controlled-substance dispensing ($315 million). On October 13, 2026 the Justice Department announced that CVS agreed to pay $315 million to resolve United States ex rel. Estright v. CVS Health Corporation, et al. (U.S. District Court for the District of Rhode Island, No. 22-cv-00222), a whistleblower case the government joined with its own complaint on December 13, 2024. The government alleged that CVS pharmacies filled opioid and other controlled-substance prescriptions in violation of the Controlled Substances Act and billed federal health programs for them in violation of the False Claims Act. The settlement covers October 17, 2013 through December 2, 2025 and is paid by CVS Pharmacy Inc. and related entities. The Justice Department states: "The claims resolved by the settlement are allegations only and there has been no determination of liability." Under a separate agreement with the DEA, CVS must run a hotline for reporting suspected illegal dispensing, actively monitor dispensing at its pharmacies and set up a process to evaluate prescribers suspected of illegal prescribing. In a statement reported by Claims Journal, CVS said it disagreed with the allegations and was not admitting wrongdoing, and that it was pleased to put the litigation behind it.

Federal Trade Commission, insulin and pharmacy-benefit practices. In September 2024 the FTC brought an administrative complaint against the three largest pharmacy benefit managers and their affiliated group purchasing organizations, including CVS subsidiaries, alleging anti-competitive and unfair rebate practices that artificially increased insulin costs. On July 14, 2026 the FTC announced a proposed consent agreement with Caremark Rx, LLC and Zinc Health Services, LLC, accepted for a 30-day public comment period by a 1-0-1 vote. The proposed terms include tying members' point-of-sale costs to the plan's net price after rebates rather than the list price, insulin programs that cap members' out-of-pocket costs, a standard plan option without rebate guarantees or spread pricing, and a monitor to receive complaints about interference with pharmacies' use of hub service providers. The FTC estimates the settlement locks in up to $8.5 billion in consumer savings over 10 years. The FTC case page lists the proposed order and no final order; CVS Health's 10-Q says the FTC will decide after the comment period whether to make the order final and has paused its litigation meanwhile.

More on regulatorsShow less

Louisiana Attorney General ($45 million). On February 20, 2026 Louisiana Attorney General Liz Murrill announced a $45 million settlement of three state lawsuits against CVS Health and its pharmacy benefit subsidiary, KPLC reported. The suits alleged misleading communications about pending legislation, violations of pharmacy-benefit regulations and unfair competition that hurt independent pharmacies. CVS did not admit liability or wrongdoing.

Insulin pens, False Claims Act ($37.76 million). On December 2, 2025 the U.S. Attorney's Office for the Southern District of New York announced that CVS Pharmacy, Inc. would pay $37.76 million, of which $24,446,240 goes to the United States and the rest to participating states, to resolve allegations that from 2010 through 2020 its pharmacies refilled insulin pens too early, dispensed more pens than patients needed and under-reported the days' supply billed to government health programs. CVS admitted and accepted responsibility for certain of this conduct. On July 9, 2026 Massachusetts Attorney General Andrea Joy Campbell announced the multistate side of the same resolution, reached with 35 other attorneys general and the Justice Department, under which CVS pays $36.5 million to the federal government and participating states. Both announcements concern the same insulin-pen allegations, so their figures should not be added together.

Vermont Attorney General (pending). On July 17, 2024 the State of Vermont sued CVS Health Corporation, CVS Caremark entities, Express Scripts entities and other defendants in Vermont Superior Court, Washington Unit, alleging that their pharmacy-benefit practices, including formulary and manufacturer-payment practices and steering patients to affiliated pharmacies, violated the Vermont Consumer Protection Act. A CVS Health spokesperson called the suit baseless and said the company would vigorously defend itself, VTDigger reported. The allegations have not been proven.

Ohio Board of Pharmacy ($250,000 fine and a 22-store settlement). On February 6, 2024 the Ohio Board of Pharmacy fined the CVS pharmacy at 7292 Fulton Drive in Canton $250,000 and placed it on probation for at least three years with enhanced monitoring, over severe understaffing in 2021. According to AP coverage, inspectors found pharmacy phones that did not work properly and a pharmacy more than a month behind in filling prescriptions; the order requires sufficient staffing and prescriptions ready within three business days. Weeks later CVS settled 27 further board cases arising from inspections of 22 Ohio stores, paying a $1.25 million penalty plus about $250,000 for enhanced monitoring, putting eight stores on three-year probation and appointing an Ohio compliance liaison pharmacist, News 5 Cleveland reported.

National opioid settlements. According to CVS Health's 10-Q for the quarter ended June 30, 2026, 45 states, the District of Columbia and all eligible U.S. territories take part in a settlement that resolves substantially all opioid claims by participating states and local governments against CVS entities; private plaintiffs are not covered. CVS settled separately with Florida, West Virginia, New Mexico and Nevada. The settlement agreement is published at nationalopioidsettlement.com. As of June 30, 2026 the company still had about $3.4 billion set aside for these opioid matters. Maryland chose not to join, and suits by some Maryland localities, other non-participating local governments such as Philadelphia, and private parties such as hospitals are still pending. In May 2026 a Florida state court entered a directed verdict for CVS and other defendants in a case brought by a group of Florida hospitals; the hospitals have appealed.

EDITORIAL

Court cases and settlements

Court records

Unless another source is named, the case descriptions on this page come from CVS Health's quarterly report (Form 10-Q) for the quarter ended June 30, 2026, and from Justice Department releases. Allegations are not findings.

Omnicare False Claims Act case (U.S. ex rel. Bassan v. Omnicare, Inc. and CVS Health Corp., U.S. District Court for the Southern District of New York, No. 1:15-cv-04179). The U.S. Attorney's Office intervened in December 2019, alleging that Omnicare dispensed drugs to residents of certain non-skilled facilities without valid prescriptions. In April 2025 a jury found Omnicare and CVS Health Corporation liable and awarded about $136 million for Omnicare's conduct, trebled by statute to about $407 million; it attributed no damages to CVS Health Corporation. In July 2025 the court imposed $542 million in penalties on Omnicare and held CVS Health Corporation jointly and severally liable for $165 million of that amount. Both companies appealed to the Second Circuit. Omnicare filed for Chapter 11 on September 22, 2025. In July 2026 CVS Health Corporation signed agreements with the Justice Department and the unsecured creditors' committee, conditioned on Bankruptcy Court approval and the sale of Omnicare's assets. According to the 10-Q, the government receives at least $440 million: CVS Health pays $130 million within two weeks of the agreements' effective date, at which point both appeals are dismissed, and CVS Health guarantees any part of a further $310 million that Omnicare's estate has not paid by March 2028. In September 2026 Judge Stacey G. C. Jernigan of the U.S. Bankruptcy Court for the Northern District of Texas approved Omnicare's Chapter 11 plan, which includes this settlement; Healthcare Dive, reporting the approval, described the deal as the government settling its judgment claim on condition that CVS pay $130 million within two weeks of the final agreement and another $310 million by the end of March 2028.

More on the lawsuitsShow less

Medicare Part D pricing case (U.S. ex rel. Behnke v. CVS Caremark Corporation, et al., U.S. District Court for the Eastern District of Pennsylvania, No. 2:14-cv-00824). A former Aetna actuary filed this whistleblower suit in February 2014, alleging that Caremark reported Part D drug-cost data that misstated the prices it actually paid pharmacies; the government declined to intervene. After a two-week bench trial the court issued a split decision, finding liability under the False Claims Act on certain claims. It trebled damages of about $95 million and added about $4.9 million in penalties, entering a judgment of about $290 million against Caremark and affiliated entities (the 10-Q gives $291 million). CVS has appealed to the Third Circuit.

Controlled-substance dispensing case (United States ex rel. Estright v. CVS Health Corporation, et al., District of Rhode Island). Settled for $315 million in October 2026 with no determination of liability; details are in the government section.

Website and app data class action (Brewer et al. v. CVS Pharmacy, Inc. and Criteo Corp., Circuit Court for Broward County, Florida, case CACE-26-008094). The suit alleges that CVS shared data about visitors to its websites and app with Criteo and other technology providers. The defendants deny violating any law, and the settlement does not decide who is right. The court granted preliminary approval on July 27, 2026 to a settlement of up to $20.5 million. People who used CVS websites or apps in the United States before July 27, 2026 can file a claim by November 16, 2026 for up to $5 without documentation or up to $10 with proof of class membership; payments shrink pro rata if claims exceed the fund. The deadline to opt out or object is November 2, 2026; class members who do not opt out are bound by the settlement whether or not they file a claim. The final approval hearing is set for December 1, 2026 and will be held by Zoom, and nothing is paid until the court grants final approval and any appeals end.

Other pending cases. The 10-Q also lists a consolidated securities class action in the Southern District of New York alleging that CVS Health misled investors about the profitability of its Health Care Benefits segment (the defendants moved to dismiss in May 2025); drug-pricing and rebate suits consolidated in multi-district litigation in the District of New Jersey; and Roofers Union Welfare Trust Fund v. CaremarkPCS Health, LLC, et al., a putative class action by Caremark clients filed in March 2026 and now in the Northern District of Illinois, alleging breach of contract, unjust enrichment and RICO violations because payments that Zinc Health Services, Caremark's affiliated group purchasing organization, received from drug manufacturers were not passed through to clients. These are allegations only.

PUBLIC RECORD

Court & Public Records

United States ex rel. Estright v. CVS Health Corporation, et al.

Settled

U.S. District Court for the District of Rhode IslandDocket 22-cv-00222Source ↗

Settled

A separate agreement with the DEA requires CVS to run a reporting hotline, monitor dispensing at its pharmacies and set up a process to evaluate suspect prescribers.

Case details: United States ex rel. Estright v. CVS Health Corporation, et al.Show less

Settled for $315 million, announced by the Justice Department on October 13, 2026. The case was filed by a former CVS employee under the whistleblower provisions of the False Claims Act; the government intervened and filed its complaint on December 13, 2024, alleging violations of the Controlled Substances Act and the False Claims Act in filling opioid and other controlled-substance prescriptions at CVS pharmacies. The settlement covers October 17, 2013 through December 2, 2025 and is paid by CVS Pharmacy Inc. and related entities. The Justice Department states that the claims are allegations only and that there has been no determination of liability.

United States ex rel. Bassan v. Omnicare, Inc. and CVS Health Corp.

Judgment

U.S. District Court for the Southern District of New YorkDocket 1:15-cv-04179Source ↗

Judgment entered

The Bankruptcy Court for the Northern District of Texas approved Omnicare's Chapter 11 plan in September 2026.

Case details: United States ex rel. Bassan v. Omnicare, Inc. and CVS Health Corp.Show less

Judgment entered in 2025; under a July 2026 settlement with the Justice Department, the appeals to the Second Circuit are to be dismissed once CVS Health makes its first payment. The U.S. Attorney's Office intervened in December 2019. In April 2025 a jury found Omnicare and CVS Health Corporation liable under the False Claims Act and awarded about $136 million for Omnicare's conduct, trebled by statute to about $407 million, with no damages attributed to CVS Health Corporation. In July 2025 the court imposed $542 million in penalties on Omnicare and held CVS Health Corporation jointly and severally liable for $165 million of that amount. Omnicare filed for Chapter 11 on September 22, 2025. Under July 2026 agreements with the Justice Department, conditioned on Bankruptcy Court approval and the sale of Omnicare's assets, the government receives at least $440 million: CVS Health pays $130 million within two weeks of the agreements' effective date, after which both appeals are dismissed, and guarantees any part of a further $310 million that Omnicare's estate has not paid by March 2028.

United States ex rel. Behnke v. CVS Caremark Corporation, et al.

Judgment

U.S. District Court for the Eastern District of PennsylvaniaDocket 2:14-cv-00824Source ↗

Judgment entered

It trebled damages of about $95 million and added about $4.9 million in penalties, for a judgment of about $290 million; CVS Health's 10-Q puts the judgment at $291 million.

Case details: United States ex rel. Behnke v. CVS Caremark Corporation, et al.Show less

Judgment entered against Caremark and affiliated entities; CVS has appealed to the Third Circuit. The whistleblower, a former Aetna actuary, filed the qui tam complaint in February 2014; it was unsealed in April 2018, and the government declined to intervene. She alleged that Caremark, CVS Health's pharmacy benefit manager, reported Medicare Part D drug-cost data that misstated the prices it actually paid pharmacies. After a two-week trial the court issued a split decision, finding liability under the False Claims Act on certain claims.

Brewer et al. v. CVS Pharmacy, Inc. and Criteo Corp.

Filed

Circuit Court of the 17th Judicial Circuit, Broward County, FloridaDocket CACE-26-008094Source ↗

Filed — no final outcome recorded

The final approval hearing is set for December 1, 2026 and will be held by Zoom.

Case details: Brewer et al. v. CVS Pharmacy, Inc. and Criteo Corp.Show less

Class settlement preliminarily approved on July 27, 2026; final approval not yet decided. The suit alleges that CVS shared data about users of its website and app with Criteo and other technology providers. The defendants deny violating any law, and the settlement does not decide which side is right. The settlement provides up to $20.5 million in total. Class members who file a claim by November 16, 2026 can receive up to $5 without documentation or up to $10 with proof of class membership, reduced pro rata if claims exceed the fund. The deadline to opt out or object is November 2, 2026.

EDITORIAL

Who operates CVS: CVS Health, CVS Pharmacy, Caremark, MinuteClinic and Aetna

CVS Health Corporation is the publicly traded parent company. Its corporate headquarters is at 1 CVS Drive, Woonsocket, Rhode Island 02895, and it is the defendant named in several of the federal cases described on this page. Before 2014 the same company filed with the SEC as CVS Caremark Corporation.

The business splits into parts that handle very different consumer problems:

More company historyShow less
  • CVS Pharmacy, Inc. runs the retail stores and store pharmacies (BBB's profile is for this company; BBB lists MinuteClinic, CVS Caremark and Longs Drugs as related businesses). Problems with a store, a prescription filled at the counter, ExtraCare or a cvs.com order belong here.
  • CVS Caremark is the pharmacy benefit manager. It works for health plans and employers: it runs their drug lists (formularies), prior authorizations and mail-order delivery. A Caremark problem is usually a question of what your plan covers, so your plan or employer benefits office is part of the route.
  • MinuteClinic runs walk-in clinics, many inside CVS stores.
  • Aetna is the group's health insurer and has its own profile on this site.

Omnicare, a CVS Health subsidiary that supplied pharmacy services to long-term-care facilities, filed for Chapter 11 on September 22, 2025, and CVS Health removed it from its consolidated accounts that quarter.

VERIFIED

Company Relationships

  • Affiliated withCVS Pharmacy, Inc.
  • Affiliated withCVS Caremark
  • Affiliated withMinuteClinic, L.L.C.
  • Affiliated withLongs Drugs
  • Affiliated withAetna
  • Affiliated withOmnicare
EDITORIAL

Frequently Asked Questions

Who is behind CVS Pharmacy?

CVS Pharmacy stores are run by CVS Pharmacy, Inc., a subsidiary of CVS Health Corporation, which is headquartered at 1 CVS Drive, Woonsocket, Rhode Island. CVS Health's other businesses include the CVS Caremark pharmacy benefit manager, MinuteClinic walk-in clinics and the health insurer Aetna; BBB also lists Longs Drugs as a related business.

What is the CVS customer service phone number?

CVS customer service is 1-800-SHOP-CVS (1-800-746-7287), the number cvs.com gives for questions and feedback about its stores, pharmacies and policies, answered Monday to Friday 8:30 a.m. to 7 p.m. and Saturday and Sunday 10 a.m. to 6:30 p.m. Eastern; cvshealth.com lists the same number for the corporate headquarters. For prescriptions managed by CVS Caremark, call the Customer Care number on your member ID card instead.

What does BBB show for CVS?

BBB's profile for CVS Pharmacy, Inc. in Woonsocket, Rhode Island shows 2,064 complaints in the last 3 years and customer reviews averaging 1.09 out of 5 stars from 404 reviews. CVS Pharmacy is not BBB accredited and has an A+ BBB rating.

What does Trustpilot show for CVS?

Trustpilot's profile for CVS Pharmacy (www.cvs.com) shows a TrustScore of 1.5 out of 5 from 3,141 reviews. The profile is unclaimed by CVS, and Trustpilot does not fact-check reviews.

What is the CVS $315 million Justice Department settlement?

On October 13, 2026 the Justice Department announced that CVS agreed to pay $315 million to resolve allegations that its pharmacies filled opioid and other controlled-substance prescriptions in violation of the Controlled Substances Act and billed federal health programs for them in violation of the False Claims Act, from October 17, 2013 through December 2, 2025. The case was brought by a former CVS employee in federal court in Rhode Island. The Justice Department states the claims are allegations only and there has been no determination of liability; in a statement reported by Claims Journal, CVS said it disagreed with the allegations and was not admitting wrongdoing. A separate DEA agreement requires a reporting hotline, active monitoring of dispensing and a process to evaluate suspect prescribers.

What is the FTC settlement with Caremark?

On July 14, 2026 the FTC announced a proposed consent agreement with Caremark Rx, LLC and Zinc Health Services, LLC to settle its 2024 case over insulin pricing and rebate practices, and opened it for public comment. The proposed terms tie members' point-of-sale drug costs to the net price after rebates, require insulin programs that cap out-of-pocket costs, and appoint a monitor for pharmacies' complaints about hub service providers. The FTC case page lists the proposal as pending, with no final order; the FTC decides after the comment period whether to make it final.

Can I claim money from the CVS digital privacy settlement?

If you used a CVS website or app in the United States before July 27, 2026, you are a class member and can file a claim by November 16, 2026 at cvsdigitalprivacysettlement.com or by mail. Claims pay up to $5 without documentation or up to $10 with proof of class membership, reduced pro rata if claims exceed the settlement of up to $20.5 million. CVS and Criteo deny violating any law. The deadline to opt out of the settlement or object to it is November 2, 2026. The final approval hearing is set for December 1, 2026; nothing is paid until the court grants final approval and any appeals are resolved.

How do I complain about CVS Caremark mail-order service?

Call the Customer Care number printed on your member ID card, or use the secure message center on caremark.com (chat is offered to some members). Describe the order, the drug and what went wrong, and ask for a written response. If the problem is a denied or non-covered drug, ask for a coverage decision in writing and appeal it through your plan; Medicare Part D members have 65 days from the date on the denial notice to ask the plan for a redetermination and can also call 1-800-MEDICARE. For employer coverage, your benefits office can explain the appeal steps and press Caremark on delays.

Was CVS Health found liable in the Omnicare case?

A federal jury in New York found Omnicare and CVS Health Corporation liable under the False Claims Act in April 2025 but attributed no damages to CVS Health Corporation. In July 2025 the court imposed $542 million in penalties on Omnicare and held CVS Health Corporation jointly and severally liable for $165 million of that amount. Both appealed. Under July 2026 agreements with the Justice Department, CVS Health pays $130 million within two weeks of the agreements' effective date, at which point both appeals are dismissed, and guarantees any part of a further $310 million that Omnicare's estate has not paid by March 2028. The Bankruptcy Court approved Omnicare's Chapter 11 plan, which includes this settlement, in September 2026.

CONSUMER ALLEGATION

Related Complaints

Names this company in a role other than the primary subject — not necessarily current or complete.